Back to Search Start Over

BRAF mutations and EGFR Intron-1 L/L genotype are associated with resistance to cetuximab plus irinotecan treatment in KRAS wild-type metastatic colorectal cancer patients

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3656..0b6d8134e6569a04366a96f78a99daa1